2025
SJR Q2
JCR Q2 · 3,5
8 matched articles
SCIE
Journal detail
Metabolomics
- Publisher
- Springer
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1573388215733890
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,936
- Quartile Q2
- H-Index 107
- Cites/doc 3,46
- Docs (3y) 331
- Cites (3y) 1.327
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,5
- 5Y JIF 3,9
- JCI 0,74
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q2
- Clinical Biochemistry Q2
- Endocrinology, Diabetes and Metabolism Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Endocrinology & Metabolism
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,936 | 3,5 | 3,9 | 0,74 | Q2 | 107 |
| 2024 | Q2 | Q2 | 0,835 | 3,3 | 3,6 | 0,76 | Q2 | 103 |
| 2023 | Q2 | Q2 | 0,74 | 3,5 | 4,1 | 0,85 | Q2 | 103 |
| 2022 | Q2 | Q3 | 0,762 | 3,6 | 4,2 | 0,89 | Q2 | 103 |
| 2021 | Q2 | Q2 | 0,866 | 4,7 | 4,8 | 0,92 | Q2 | 103 |
| 2020 | Q2 | Q2 | 0,919 | 4,3 | 4,2 | 0,81 | Q2 | 103 |
| 2019 | Q2 | Q3 | 0,875 | 2,9 | 3,6 | 0,83 | Q2 | 103 |
| 2018 | — | Q2 | — | 3,2 | 3,6 | 0,9 | Q2 | — |
| 2017 | Q1 | Q2 | 1,122 | 3,5 | 3,8 | 0,92 | Q2 | 103 |
| 2016 | Q1 | Q2 | 1,186 | 3,7 | 3,9 | — | — | 103 |
| 2015 | Q1 | Q2 | 1,318 | 3,7 | 3,9 | — | — | 103 |
| 2014 | Q1 | Q2 | 1,309 | 3,9 | 4 | — | — | 103 |
| 2013 | Q2 | Q2 | 1,133 | 4 | 4,6 | — | — | 103 |
| 2012 | Q1 | Q1 | 1,225 | 4,4 | 4,7 | — | — | 103 |
| 2011 | Q1 | Q1 | 1,372 | 4,5 | 4,5 | — | — | 103 |
| 2010 | Q1 | Q2 | 1,165 | 3,6 | 3,6 | — | — | 103 |
| 2009 | — | Q2 | — | 3,9 | 3,8 | — | — | — |
| 2008 | — | Q2 | — | 3,3 | 3,7 | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 87/198 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 80/193 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 68/186 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 77/145 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 54/146 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 60/146 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q2 | 87/143 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 71/145 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q2 | 53/142 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 45/138 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 40/133 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 41/128 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 35/124 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 29/122 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 27/122 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 38/116 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 31/105 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 35/93 |